Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal epithelial tight junction proteins form specialized intercellular junctions located at the apical part of the epithelium between neighboring cells. They constitute a critical component of the intestinal barrier, regulating paracellular permeability and maintaining epithelial integrity. These dynamic protein complexes consist of transmembrane proteins (occludin, claudins, JAMs, tricellulin) that interact across the intercellular space and peripheral proteins (ZO-1, ZO-2, ZO-3) that connect to the cytoskeleton. Their proper function is essential for intestinal health, and their dysregulation is implicated in various pathological conditions including inflammatory bowel disease, obesity, and other metabolic disorders.
Targeting signaling pathways that regulate TJ formation and disassembly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial tight junction proteins (TJ proteins).